Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer

Clinical Trials, High Risk Prostate Cancer, Metastatic Castration Sensitive Prostate Cancer (MCSPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT06173362
Phase: PHASE2
Trial Summary: This phase II trial compares the effects, good and/or bad of abiraterone and prednisone or darolutamide alone in treating patients with prostate cancer that may have spread from where it first started – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Mamta Parikh
Acronym:

Pin It on Pinterest